Rapid and profound changes are taking place in the field of hepatitis C therapeutics. More than ever, these changes necessitate a current, clinically pertinent review of the …
The field of healthcare epidemiology and infection prevention is evolving with the emergence of new pathogens, new resistance patterns, new treatment options, and new pressures for …
Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, …
